ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ZVSA ZyVersa Therapeutics Inc

4.41
-0.34 (-7.16%)
Jun 07 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 21,932
Bid Price 4.40
Ask Price 4.72
News -
Day High 4.815

Low
3.94

52 Week Range

High
141.89

Day Low 4.48
Company Name Stock Ticker Symbol Market Type
ZyVersa Therapeutics Inc ZVSA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.34 -7.16% 4.41 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.71 4.48 4.815 4.41 4.75
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
397 21,932 $ 4.60 $ 100,985 - 3.94 - 141.89
Last Trade Time Type Quantity Stock Price Currency
19:59:02 30 $ 4.72 USD

ZyVersa Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
27.97M 1.24M - 0 -106.25M -85.46 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ZyVersa Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ZVSA Message Board. Create One! See More Posts on ZVSA Message Board See More Message Board Posts

Historical ZVSA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.955.303.954.88186,6130.4611.65%
1 Month5.185.523.944.8180,441-0.77-14.86%
3 Months7.86510.203.946.86500,230-3.46-43.93%
6 Months12.3025.003.949.331,653,580-7.89-64.15%
1 Year136.885141.893.9440.733,172,512-132.48-96.78%
3 Years4,900.005,232.503.9487.502,476,292-4,895.59-99.91%
5 Years4,900.005,232.503.9487.502,476,292-4,895.59-99.91%

ZyVersa Therapeutics Description

ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases.

Your Recent History

Delayed Upgrade Clock